首页> 美国卫生研究院文献>Microbial Cell Factories >Construct design production and characterization of Plasmodium falciparum 48/45 R0.6C subunit protein produced in Lactococcus lactis as candidate vaccine
【2h】

Construct design production and characterization of Plasmodium falciparum 48/45 R0.6C subunit protein produced in Lactococcus lactis as candidate vaccine

机译:乳酸乳球菌产生的恶性疟原虫恶性疟原虫48/45 R0.6C亚基蛋白的构建设计生产和表征作为候选疫苗

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BackgroundThe sexual stages of Plasmodium falciparum are responsible for the spread of the parasite in malaria endemic areas. The cysteine-rich Pfs48/45 protein, exposed on the surface of sexual stages, is one of the most advanced antigens for inclusion into a vaccine that will block transmission. However, clinical Pfs48/45 sub-unit vaccine development has been hampered by the inability to produce high yields of recombinant protein as the native structure is required for the induction of functional transmission-blocking (TB) antibodies. We have investigated a downstream purification process of a sub-unit (R0.6C) fragment representing the C-terminal 6-Cys domain of Pfs48/45 (6C) genetically fused to the R0 region (R0) of asexual stage Glutamate Rich Protein expressed in Lactococcus lactis.
机译:背景恶性疟原虫的性期是疟原虫在疟疾流行地区传播的原因。暴露于性生活阶段表面的富含半胱氨酸的Pfs48 / 45蛋白是包含在能阻止传播的疫苗中的最先进的抗原之一。但是,由于无法诱导诱导功能性传导阻滞(TB)抗体需要天然结构,因此无法产生高产量的重组蛋白阻碍了临床Pfs48 / 45亚单位疫苗的开发。我们已经研究了一个亚单位(R0.6C)片段的下游纯化过程,该片段代表通过遗传融合至表达的无性谷氨酸丰富蛋白的R0区(R0)的Pfs48 / 45(6C)的C末端6-Cys域在乳酸乳球菌中。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号